Author

Rosine Fellmann-Clauss

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Claire Gavériaux‐RuffiD· 1 shared Dominique BonnetiD· 1 shared François DaubeufiD· 1 shared Frédéric SimoniniD· 1 shared Glenn-Marie Le Coz· 1 shared Lucie Estéoulle· 1 shared Nathalie Petit-Demoulière· 1 shared Nicolas HumbertiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Claire Gavériaux‐RuffORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A metabolically resistant spexin analogue, LIT-01-144, induces potent non-opioid peripheral antinociception in persistent pain via activation of GALR2

Yann Berthomé, Glenn-Marie Le Coz, Valérie Utard, Qiuxiang Gu, Rosine Fellmann-Clauss, Nathalie Petit-Demoulière, Raphäelle Quillet, Claire Gavériaux‐Ruff, Sridévi M. Ramanoudjame, Lucie Estéoulle, Nicolas Humbert, François Daubeuf, Patrick Gizzi, Stéphanie Riché, Xavier Leroy, , Frédéric Simonin

This study develops a spexin analog, LIT-01-144, that activates GALR2 to provide potent non-opioid antinociception in persistent pain without central nervous system penetration.

bioRxiv · Feb 20, 2026 · PreprintPharmacology & Toxicology